<DOC>
	<DOCNO>NCT00885079</DOCNO>
	<brief_summary>The purpose study verify whether OPC-12759 ophthalmic suspension effective compare active control dry eye patient .</brief_summary>
	<brief_title>Confirmatory Study OPC-12759 Ophthalmic Suspension</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>1 . Out patient 2 . Subjective complaint dry eye present minimum 20 month 3 . Ocular discomfort severity moderate severe 4 . Corneal conjunctival damage moderate severe 5 . Unanesthetized Schirmer 's test score 5mm/5minutes less 6 . Best correct visual acuity 0.2 good eye 1 . Presence anterior segment disease disorder associate keratoconjunctivitis sicca 2 . Ocular hypertension patient glaucoma patient ophthalmic solution 3 . Anticipated use topicallyinstilled ocular medication patient discontinue use study 4 . Anticipated use contact lens study 5 . Patient punctal plug 6 . Any history ocular surgery within 12 month 7 . Female patient pregnant , possibly pregnant breast feed 8 . Known hypersensitivity component study drug procedural medication 9 . Receipt investigational product within 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>